Through downstream analysis, we highlight disease-relevant, translatable pQTLs by presenting new evidence supporting protein-disease associations; most notably, CD33 and Alzheimer’s disease, GPNMB and Parkinson’s disease, and MSR1 and schizophrenia. This evidence concerns the gene CD33 and Parkinson disease.